Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flesch

Showing results (101-110 of 154) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II studyC Louvet, T André, G Lledo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Prevention of graft-versus-host disease in HLA-matched bone marrow transplantation for malignant diseases: a multicentric study of 62 patients using 3-pan-T monoclonal antibodies and rabbit complementE Racadot, P Hervé, F Beaujean, et al.
Archives Francaises De Pediatrie|June 1, 1985
[Autograft of bone marrow following intensive treatment in acute lymphoid leukemia in children]E Plouvier, P Hervé, A Noir, et al.
Blood|September 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind placebo-controlled trialN C Gorin, B Coiffier, M Hayat, et al.
Blood|June 15, 1992
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host diseaseP Hervé, M Flesch, P Tiberghien, et al.
Transplantation|September 1, 1991
Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatmentP Tiberghien, E Racadot, B Lioure, et al.
Presse Medicale (Paris, France : 1983)|February 6, 1988
[Prolonged remission of Burkitt's lymphoma stage IV secondary to Hodgkin's disease]J Y Cahn, M Flesch, A Rozenbaum, et al.
European Journal of Haematology. Supplementum|January 1, 1989
Allogeneic bone marrow transplantation in patients with multiple myelomaG Gahrton, S Tura, C Belanger, et al.
Blood|February 1, 1987
Successful graft-versus-host disease prevention without graft failure in 32 HLA-identical allogeneic bone marrow transplantations with marrow depleted of T cells by monoclonal antibodies and complementP Hervé, J Y Cahn, M Flesch, et al.
Nouvelle Revue Francaise D'Hematologie|July 1, 1994
[Mitoxantrone-aracytine with or without quinine in the treatment of refractory or relapsed acute leukemia]E Solary, F Witz, P Moreau, et al.
Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II studyC Louvet, T André, G Lledo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Prevention of graft-versus-host disease in HLA-matched bone marrow transplantation for malignant diseases: a multicentric study of 62 patients using 3-pan-T monoclonal antibodies and rabbit complementE Racadot, P Hervé, F Beaujean, et al.
Archives Francaises De Pediatrie|June 1, 1985
[Autograft of bone marrow following intensive treatment in acute lymphoid leukemia in children]E Plouvier, P Hervé, A Noir, et al.
Blood|September 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind placebo-controlled trialN C Gorin, B Coiffier, M Hayat, et al.
Blood|June 15, 1992
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host diseaseP Hervé, M Flesch, P Tiberghien, et al.
Transplantation|September 1, 1991
Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatmentP Tiberghien, E Racadot, B Lioure, et al.
Presse Medicale (Paris, France : 1983)|February 6, 1988
[Prolonged remission of Burkitt's lymphoma stage IV secondary to Hodgkin's disease]J Y Cahn, M Flesch, A Rozenbaum, et al.
European Journal of Haematology. Supplementum|January 1, 1989
Allogeneic bone marrow transplantation in patients with multiple myelomaG Gahrton, S Tura, C Belanger, et al.
Blood|February 1, 1987
Successful graft-versus-host disease prevention without graft failure in 32 HLA-identical allogeneic bone marrow transplantations with marrow depleted of T cells by monoclonal antibodies and complementP Hervé, J Y Cahn, M Flesch, et al.
Nouvelle Revue Francaise D'Hematologie|July 1, 1994
[Mitoxantrone-aracytine with or without quinine in the treatment of refractory or relapsed acute leukemia]E Solary, F Witz, P Moreau, et al.
Pageof 16